Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
58.54
-4.95 (-7.80%)
At close: Apr 1, 2025, 4:00 PM
59.31
+0.77 (1.31%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Verona Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
399.76271.77227.83148.38187.99
Upgrade
Cash & Short-Term Investments
399.76271.77227.83148.38187.99
Upgrade
Cash Growth
47.09%19.29%53.54%-21.07%360.66%
Upgrade
Accounts Receivable
31.5----
Upgrade
Other Receivables
5.7610.959.2815.588.26
Upgrade
Receivables
37.2610.959.2815.588.26
Upgrade
Inventory
6.25----
Upgrade
Prepaid Expenses
7.573.622.54.044.54
Upgrade
Other Current Assets
2.743.373.392.061.72
Upgrade
Total Current Assets
453.57289.71243170.06202.5
Upgrade
Property, Plant & Equipment
3.152.870.930.981.16
Upgrade
Long-Term Investments
15151515-
Upgrade
Goodwill
0.550.550.550.550.55
Upgrade
Other Long-Term Assets
1.97----
Upgrade
Total Assets
474.24308.12259.47186.59204.21
Upgrade
Accounts Payable
11.273.492.9110.040.18
Upgrade
Accrued Expenses
17.863.5913.7522.2610.86
Upgrade
Current Portion of Long-Term Debt
0.69----
Upgrade
Current Portion of Leases
1.121.180.680.650.8
Upgrade
Current Income Taxes Payable
8.89-0.280.15-
Upgrade
Other Current Liabilities
2.860.441.410.332.36
Upgrade
Total Current Liabilities
42.688.6919.0333.4214.2
Upgrade
Long-Term Debt
225.7648.379.774.874.64
Upgrade
Long-Term Leases
1.241.780.210.290.51
Upgrade
Total Liabilities
269.6858.842938.5819.35
Upgrade
Common Stock
45.0242.7740.5331.8631.79
Upgrade
Additional Paid-In Capital
728.2601.06529.19385.07366.41
Upgrade
Retained Earnings
-562.4-388.43-333.1-263.72-207.05
Upgrade
Treasury Stock
-1.66-1.52-1.55-0.6-1.7
Upgrade
Comprehensive Income & Other
-4.6-4.6-4.6-4.6-4.6
Upgrade
Shareholders' Equity
204.56249.28230.47148.01184.85
Upgrade
Total Liabilities & Equity
474.24308.12259.47186.59204.21
Upgrade
Total Debt
228.8151.3310.655.815.95
Upgrade
Net Cash (Debt)
170.95220.44217.18142.57182.04
Upgrade
Net Cash Growth
-22.45%1.50%52.33%-21.68%360.33%
Upgrade
Net Cash Per Share
2.102.783.282.415.54
Upgrade
Filing Date Shares Outstanding
84.9886.8378.9960.3757.93
Upgrade
Total Common Shares Outstanding
84.6380.4475.7960.0157.91
Upgrade
Working Capital
410.89281.02223.97136.64188.3
Upgrade
Book Value Per Share
2.423.103.042.473.19
Upgrade
Tangible Book Value
204.01248.74229.92147.46184.31
Upgrade
Tangible Book Value Per Share
2.413.093.032.463.18
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q